EX-10.42



 Exhibit 10.42 
 SEVENTH AMENDMENT 
 TO DEVELOPMENT AND SUPPLY AGREEMENT 

Effective as of date of the last signature below, Abbott Laboratories, an Illinois corporation having a principal place of business at
100 Abbott Park Road, Abbott Park, Illinois 60064-3500 (“Abbott”), and Seattle Genetics, Inc., a Delaware corporation having a principal place of business at 21823 – 30th Drive Southeast in Bothell, Washington 98021 (“Seattle
Genetics”) (individually the “Party” or collectively the “Parties”) agree to the following terms and conditions (this “Seventh Amendment”) as set forth below. 

WHEREAS, the Parties entered into a Development and Supply Agreement with an Effective Date of February 23, 2004 for the
manufacture of a chimeric anti-CD30 AC10 monoclonal antibody known as cAC10 Bulk Drug Substance (the “Original Agreement”), which also constitutes the antibody component of SGN-35 and the Parties subsequently entered into six amendments to
the Original agreement (the “First Amendment”, “Second Amendment”, “Third Amendment”, “Fourth Amendment”, “Fifth Amendment” and “Sixth Amendment”, respectively. Collectively the Original
Agreement, the First Amendment, the Second Amendment, the Third Amendment, the Fourth Amendment, the Fifth Amendment and the Sixth Amendment are hereinafter referred to as the “Agreement”); and 

WHEREAS, the Parties desire to further amend the Agreement as herein provided as of the date hereof. 

NOW, THEREFORE, in consideration of the mutual covenants and agreements contained here and for other good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties agree as follows: 
 1. Incorporation
of the Agreement. All capitalized terms which are used but not otherwise defined herein shall have the same meanings as set forth in the Agreement, and the Agreement, to the extent not inconsistent with this Seventh Amendment, is incorporated
herein by this reference as though the same was set forth in its entirety. To the extent any terms and provisions of the Agreement are inconsistent with the amendments set forth in Paragraphs 2 and 3 below, such terms and provisions shall be deemed
superseded hereby. Except as specifically set forth herein, the Agreement shall remain in full force and effect and its provisions shall be binding on the parties. 
 2. Process Development Work. The Parties agree that Abbott shall perform the activities set forth in Stage 13a of Attachment 1 hereto pursuant to the terms and conditions of the Agreement.

 3. Payment Schedule. As compensation for the activities to be performed by Abbott pursuant to Attachment 1 hereto,
Seattle Genetics shall pay to Abbott the price established for each project stage on the dates set forth in Attachment 2. Billings associated with this Seventh Amendment may be combined on the same invoice with other, regular Payment Schedule
charges. 
 4. Project References. All references to the Project set forth in the Agreement, with the exception of the
Payment Schedule and Facility Reservation Fee for the Project, shall also be deemed to apply to the activities performed by Abbott, pursuant to this Seventh Amendment. 

 
 Confidential treatment has been requested for portions of this document.
This document omits the information subject to the 
 confidential treatment request. Omissions are designated as ***. A complete version
of this document has been filed separately with 
 the Securities and Exchange Commission. 







 6. Effectuation. The amendment to the Agreement contemplated by this Seventh
Amendment shall be deemed effective as of the last date written below upon the full execution of this Seventh Amendment and without any further action required by the parties hereto. There are no conditions precedent or subsequent to the
effectiveness of this Seventh Amendment. All terms and conditions set forth in Agreement that are not amended hereby shall remain in full force and effect. Any term of this Seventh Amendment may be amended with the written consent of both parties.
From the date hereof, any reference to the Agreement shall be deemed to refer to the Agreement as amended by this Seventh Amendment. 
 7. Counterparts. This Seventh Amendment may be executed in two or more counterparts, each of which shall be deemed to be an original, but all of which together shall constitute one and the same
instrument. One or more counterparts of this Seventh Amendment may be delivered by facsimile, with the intention that delivery by such means shall have the same effect as delivery of an original counterpart thereof. 

8. Entire Agreement. This Seventh Amendment and exhibits hereto are the product of both of the Parties hereto, and together with
the Agreement and exhibits thereto constitute the entire agreement between such parties pertaining to the subject matter hereof, and merge all prior negotiations and drafts of the Parties with regard to the transactions contemplated herein.

 IN WITNESS WHEREOF, the parties have executed Second Amendment of the dates set forth below. 

 

							
	ABBOTT LABORATORIES 	  	SEATTLE GENETICS, INC.
				
	By:	 	  /s/ Keith Kentala
	  	By:	  	  /s/ Clay B. Siegall

	Name: Keith Kentala	  	Name: Clay. B. Siegall
	Title: General Manager, Commercial Operations	  	Title: President & CEO
	Date: 01/02/2013	  	Date: 12/19/12








 STAGE 13A: REFERENCE STANDARD GENERATION AND STABILITY 

[***]. 
 Table 1: Reference Standard Testing
– Qualification and Stability (i.e. Re-evaluation) Testing 
  

																									
	 Storage Temperature
	  	Time point (Months)	 
	  	 	[	***] 	 	 	[	***] 	 	 	[	***] 	 	 	[	***] 	 	 	[	***] 	 	 	[	***] 
	 [***]
	  	 	[	***] 	 	 	[	***] 	 	 	[	***] 	 	 	[	***] 	 	 	[	***] 	 	 	[	***] 

 [***] 
 Seattle
Genetics Deliverables: 
 [***] 
 Abbot
Deliverables: 
 [***] 
 Price:

  

					
	 Reference standard generation & year [***] testing:
	  	 	$[***]	  
	 Stability testing – years [***] through [***]
	  	 	$[***]	  
		  	  
	  
	 
	 Total
	  	 	$[***]        	  

  

	***	Confidential treatment has been requested with respect to the redacted portions of the referenced exhibit. 








 PAYMENT SCHEDULE 

[***] 

2012 
  

																																																							
	 Stage
	  	 Activities
	  	Jan	 	  	Feb	 	  	Mar	 	  	Apr	 	  	May	 	  	Jun	 	  	Jul	 	  	Aug	 	  	Sep	 	  	Oct	 	  	Nov	 	  	Dec	 	  	Year	 
	13A	  	 Reference Std Gen and Testing
	  				  				  				  				  				  				  				  				  				  				  	 	[***]	  	  				  	 	[***]	  
	13A	  	 Reference Std Gen and Testing
	  				  				  				  				  				  				  				  				  				  				  	 	[***]	  	  				  	 	[***]	  
		  	 Total
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  

 2013 
  

																																																							
	 Stage
	  	 Activities
	  	Jan	 	  	Feb	 	  	Mar	 	  	Apr	 	  	May	 	  	Jun	 	  	Jul	 	  	Aug	 	  	Sep	 	  	Oct	 	  	Nov	 	  	Dec	 	  	Year	 
	13A	  	 Reference Std Gen and Testing
	  				  				  				  				  				  				  				  				  				  				  	 	[***]	  	  				  	 	[***]	  
	13A	  	 Reference Std Gen and Testing
	  				  				  				  				  				  				  				  				  				  				  	 	[***]	  	  				  	 	[***]	  
		  	 Total
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  

 2014 
  

																																																							
	 Stage
	  	 Activities
	  	Jan	 	  	Feb	 	  	Mar	 	  	Apr	 	  	May	 	  	Jun	 	  	Jul	 	  	Aug	 	  	Sep	 	  	Oct	 	  	Nov	 	  	Dec	 	  	Year	 
	13A	  	 Reference Std Gen and Testing
	  				  				  				  				  				  				  				  				  				  				  	 	[***]	  	  				  	 	[***]	  
	13A	  	 Reference Std Gen and Testing
	  				  				  				  				  				  				  				  				  				  				  	 	[***]	  	  				  	 	[***]	  
		  	 Total
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  

 2015 
  

																																																							
	 Stage
	  	 Activities
	  	Jan	 	  	Feb	 	  	Mar	 	  	Apr	 	  	May	 	  	Jun	 	  	Jul	 	  	Aug	 	  	Sep	 	  	Oct	 	  	Nov	 	  	Dec	 	  	Year	 
	13A	  	 Reference Std Gen and Testing
	  				  				  				  				  				  				  				  				  				  				  	 	[***]	  	  				  	 	[***]	  
	13A	  	 Reference Std Gen and Testing
	  				  				  				  				  				  				  				  				  				  				  	 	[***]	  	  				  	 	[***]	  
		  	 Total
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  

 2016 
  

																																																							
	 Stage
	  	 Activities
	  	Jan	 	  	Feb	 	  	Mar	 	  	Apr	 	  	May	 	  	Jun	 	  	Jul	 	  	Aug	 	  	Sep	 	  	Oct	 	  	Nov	 	  	Dec	 	  	Year	 
	13A	  	 Reference Std Gen and Testing
	  				  				  				  				  				  				  				  				  				  				  	 	[***]	  	  				  	 	[***]	  
	13A	  	 Reference Std Gen and Testing
	  				  				  				  				  				  				  				  				  				  				  	 	[***]	  	  				  	 	[***]	  
		  	 Total
	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  	  	 	[***]	  

  

	***	Confidential treatment has been requested with respect to the redacted portions of the referenced exhibit.